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Abstract
End-stage renal disease (ESRD) is a progressive disorder
for which there is no prospect of recovery, and for which
patients receive regular haemodialysis. In ESRD the ability
of the kidneys to excrete metabolic waste products and to
regulate the composition of extracellular fluid is
compromised. Symptoms of ESRD also include
cardiovascular dysfunction, anaemia, malnutrition,
muscle wasting, muscle weakness, glucose intolerance
and reduced bone density. Patients with ESRD are likely to
be challenged by participation in exercise whilst
undergoing a HD regimen. Nevertheless there is a case for
prescribing exercise in patients who struggle to become
active. Some benefits of exercise In patients receiving
haemodialysis, the benefits of physical exercise, which
include: 1) Reduction of toxins and fluid overload in the
circulatory system, permitting improved tolerance to the
HD regimen and 2) Increased heart rate, which improves
cardiovascular performance, 3) a reduction in
comorbidities and an increase in well-being, and 4) the
facilitation of positive coping strategies. An understanding
how exercise can be of clinical advantage in ESRD patients
is unique and challenging given the variety of nutritional
and clinical conditions with which they present. The
haematological and biochemical parameters which should
be monitored in these patients (including blood
potassium, urea, calcium and hemoglobin levels) need to
be prioritized, and this prioritization depends in turn upon
general patient well-being. More research is also required
in the understanding of physiology and importance of
good nutrition in this population. The aim of this work is
to provide some background of the key parameters in HD
patients and to identify literature on biochemical
parameters which are affected during physical activity in
HD patients. The results help to emphasize that closer
attention should be paid to monitoring HD efficacy and
Kt/V, a measure of dialysis adequacy.
Keywords: Nephrology; Physical activity; Haemodialysis;
Chronic kidney disease; Kt/v
Introduction
Haemodialysis (HD) is a form of renal replacement therapy
(RRT) as is continuous ambulatory peritoneal dialysis (CAPD).
Although different in their protocols, both forms of treatment
allow a steady-state of clinical biochemical and haematological
parameters [1]. These include creatinine, urea, sodium,
calcium, and other important components. It should be
acknowledged; patients who have poor treatment efficacy
(identified using Kt/V measurement) will feel worse over time.
Physical activity may be an important factor in dialysis
adequacy/efficiency (be it short-term or long-term) and in
preparation for patients awaiting a transplant.
It is known that vigorous physical activity (particular intense
cardiovascular workout) has many benefits. Some of the
parameters that are affected include: β-endorphin, reduced
urea, and positive psychology. These all benefit in the
preparation to transplantation. However, at present there is
little evidence that collaborates physical activity, stress and the
parameters that are/should be monitored closely in the HD
population; more efforts are being made to interrogate
exercise literature (or physical activity research) and renal
health. One study used two groups of athletes [1]. One of
these groups represented subjects with a range of fitness
levels from recreational to high-performance running. The
second group represented canoeists with a similar range of
fitness levels. The study measured the in vitro responses of
leukocytes following acute anaerobic exercise over a 24 h
recovery period. There was a reduction in proliferative
lymphocyte response which was shown to be brief and
transient. Other research investigating how physical activity
effects specific immunological parameters demonstrated that
prolonged endurance exercise causes an increase in plasma
levels of interleukin-1 (Il-1), possibly as a response to muscle
injuries, but plasma interleukin-2 levels were generally
reduced [2]. IL-1 secretion may enhance the responsiveness of
peripheral blood mononuclear cells, but prostaglandin
secretion decreases their IL-2 production. The observations
may have been due to altered IL-2 levels or Il-2 receptor
expression. In this study, appropriately graded physical activity
reduces the adverse immune reactions associated with
challenging exercise. This study gives general information
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also informed how through the immune system,
transplantation and psychological stress, some biochemical
parameters are more affected than others [4].
Aim of this Work
This work aims to provide some background on key
haematological and biochemical parameters which are
measured in HD patients, and in addition to identify literature
on biochemical parameters specifically influenced by physical
activity in HD patients. I will conclude that closer attention to
monitoring HD efficacy and Kt/V is needed.
General Benefits of Physical Activity in
HD Patients
It has been documented that physical activity as measured
by peak oxygen uptake is generally low in HD patient groups
[5-9]. There are a number of factors that may contribute to
this, including anaemia, cardiac dysfunction (reduced
contractility and increased preload and afterload of ventricular
muscle), vascular dysfunction (a limitation in the capacity to
divert cardiac output to skeletal muscle), skeletal muscle
abnormalities (reduced fibre size, capillary density,
mitochondrial density/function, increased diffusion distance)
and/or metabolic abnormalities and autonomic nervous
system dysfunction [10-17]. At the same time, physical activity
has the following benefits in HD patients: Some benefits of
exercise in HD patients include: 1) Reduces toxins in the blood
and fluid overload, thus allowing patients to tolerate HD
regimen better and 2) Exercise increases heart rate, which in
turn also allows increases strength to cardiovascular system, 3)
Because of the increased heart rate during exercise/physical
activity, this will in turn allow an increase blood flow through
vascular system (fistulae access, especially), which then means
patients would get better Kt/V results overall, 4) Exercise will
reduce the amount of fluid to come off during HD, 5) Exercise
causes an increase in β-endorphin hormone, which causes a
state of ‘feeling good'-this in turn prompts a positive mental
attitude despite overwhelming circumstances, 5) A long-term
physical activity protocol (2-3 times a week) in HD patients
may be one of the best ways for the body to prepare for a
renal transplant [4]. Exhaustion post exercise generally causes
a period where there is an activated immune response. This is
not necessarily the same immune response as evident during a
cold or an infection or even post transplantation. This is
because during bouts of intense exercise, there is secretion of
β- endorphins and 6) Exercise can aid to cope with traumatic
procedures such as fistulae and other forms of access creation
[4].
Physical Activity in Post-Transplant
Patients
Post-transplant CKD patients cannot participate in exercise
to the same extend as in normal patients, and this is
expected because they are at higher risk of cardiovascular
disease [5-8]. Research suggests an association between
higher physical activity levels and slower rate of estimated
glomerular filtration rate (eGFR) loss in patients with CKD
stages 3 and 4 [9]. Experimental interventions to improve
cardiovascular risk factors or renal function by increasing
exercise capacity in patients. In post-transplant patients,
procedures and protocols differ from the HD patient. The most
challenging period post-transplant is the initial 3-6 months,
where the immune system is adapting/or tolerating the ‘new'
organ. For many patients this period is stressful and strenuous.
The initial phases post-transplant involves ‘constant'
observation of creatinine (being the main clinical parameter);
in addition to ensuring the immunosuppression dosage/titres
are correct. A renal biopsy is quite common in early post-
transplant and this brings on various additional emotions [4].
Exercise is recommended (but not prescribed) in the ‘late'
post-transplant period, where clinical chemistry parameters
are less susceptible to ‘blips'. Exercise generally improves
coping, regardless of whether on an HD regime or
transplanted. Patients who exercise ‘later' post-transplant will
also have reduced episodes of stress, depression and
frustration. Physical activity may also indirectly aid to reduce
episodes of AAR [4] because increase blood flow through
afferent and efferent arterioles of the kidneys.
Biochemical Parameters in HD
Patients 
Urea
Urea is a small molecule produced from protein and it is
excreted by the kidneys in normal renal function; when renal
function declines, urea levels rise [16,18]. It is synthesized by
the reactions of the urea cycle from carbamoyl phosphate and
ammonium ions, the latter being derived from deamination
reactions [16,18]. It is not such an accurate test for kidney
function as creatinine, but is a useful test when used together
with creatinine, because it is affected by muscle breakdown,
how much protein consumed and whether a patient has
consumed enough fluid (it rises if dehydrated). The normal
range=2.5 mmol/l to 7.1 mmol/l (7-20 mg/dl) [16,18].
Potassium
Potassium is important for cellular/interstitial fluid balance
and for normal function of the heart, kidneys and other
organs. A diet includes fruit (notably bananas), vegetables and
protein provides the normal daily allowance of potassium.
Potassium is also available in supplements, but the intake of
too much potassium can be harmful, especially for people with
renal disease or those taking some drugs to treat hypertension
[16,18]. Potassium in is critical for maintaining the normal
electrical rhythm of the heart and nerve impulses. The normal
potassium level in the blood is 3.5 mEq/L to 5.0 mEq/L (milli
Equivalents per liter). Potassium levels between 5.1 mEq/L to
6.0 mEq/L are considered to represent mild hyperkalemia
[16,18].
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Calcium
There is a broad normal physiological range of total and free
Calcium concentrations, depending on age, sex, physiological
state (e.g. pregnancy), combined with seasonal variations
which follow a variation in the blood level of vitamin D, directly
involved in the regulation of calcium concentration [16,18]. In
HD patients, calcium and phosphate mineral metabolism is
compromised owing to the attribute renal insufficiency and
decline in renal function. The corrected total serum calcium
concentration is normally 8.5 mg/dL to 10.2 mg/dL, but there
is no absolute reference point for serum calcium levels either
in hypocalcemia or hypercalcemia, at which adverse symptoms
will occur [16,18]. Table 1 provides a summary of clinical
biochemical variables obtained from the UK Renal Registry
(UKRR).
Table 1 A summary of clinical biochemical variables.
Biochemical
Variable
Clinical Audit Measure Conversion Factor
from SI Units
Phosphate HD Patients: 1.1-1.7 mmol/l Mg/dl=mmol/l × 3.1
PD Patients: 1.1-1.7 mmol/l
Calcium (adjusted) Normal range (<2.5 mmol/l) Mg/dl=mmol/l × 4
Parathyroid
hormone
2-9 times upper limit of
normal
Mg/dl=mmol/l × 9.5
Bicarbonate HD Patients: 18-24 mmol/l Mg/dl=mmol/l × 6.1
PD Patients: 22-30 mmol/l
Ref: Table adapted from [19]
Relevance of Kt/V
Kt/V is used to measure the effectiveness of HD treatment,
and involves the measurement of blood urea before and after
treatment, to show how much toxin has been removed from
the blood. URR is a simpler test of HD effectiveness: some
units use URR, some use Kt/V, some use both. In the UK the
accepted target for Kt/V is a minimum of 1.2, (the optimum
target is between 1.6 and 1.8+) [18]. A slightly lower value may
be acceptable if a patient has some renal function (eGFR=15%
+). Lower values are associated with a poorer HD poorer
prognosis. If HD patients exercise, the majority of clinical
chemistry parameters will stay stable; this ultimately enhances
HD efficiency [18]. Table 2 summarizes how patients can
achieve higher Kt/V values.
It must be noted that not all patients will be able to achieve
high Kt/V results owing to pre-determined vascular
complications.
Importance of Creatinine in HD
patients
Effectively, creatinine is a by-product of muscle break-down.
Because a majority of recipients on HD and CAPD do not have
relative renal function, the creatinine will stay above the
normal range (60 mmol/l to 120 mmol/l or 0.7 mg/dl to 1.4
mg/dl). The creatinine will not necessarily be of significant
difference when compared to a patient who has been
transplanted, simply because regardless of HD efficacy, the
quantity of blood processed/replenished is limited in
comparison to the function of a native kidney/transplant.
Creatinine is thus not specifically an important biomarker for
renal function in HD patients; however it is important for
muscle mass which is why protein is also important in these
patients because it strengthens cardiac muscle and body mass
[18].
Table 2 How patients can achieve higher Kt/V results.
Increasing HD Efficiency
Large gauge/Barrel needles post fistulae maturation
4.5 hours; 3 times a week
Good spread of needles across access
Increased dialysate flow (600mls/min to 700 mls/min)
Physical activity in between or during HD treatment
Ref: Table adapted from [20]
Haematological Parameters in HD
Patients
In ESRD, serum free iron concentration, and iron-saturation
of transferrin, and ferritin are usually normal. Non-heme iron
absorption from the gut is also normal. This has been observed
in detailed studies on iron kinetics, where it has been
proposed that, in view of the increased levels which can occur
in response to acute anaemia or hypoxic hypoxia in ESRD
patients, a decoupling between the endocrine and the
excretory function of the kidney is responsible rather than its
inability to produce erythropoietin [21].
The improvement in anaemia symptoms after starting
haemodialysis was first described in 1970. It was postulated
that this was due to the presence of the uremic inhibitors of
erythropoiesis in the plasma. Polar lipids, arsenic, spermine
and spermidine, vitamin A, and the parathyroid hormone are
possible sources of uremic inhibition. Aluminium overload in
haemodialysis patients is also proposed to cause microcytic
anaemia, probably by inhibiting erythroid marrow as a result
of binding to transferrin [22,23]. Blood loss, amounting to 4 ml
to 20 ml, is associated with the dialysis procedure, with
additional loss resulting from frequent blood sampling. As a
result a patient who is on dialysis may lose in excess of 2 mg of
iron per day. In addition, chronic infection and chronic
inflammation may play a major role in the pathogenesis of
anaemia [23]. One study has identified apparent microcytic
hypochromic anaemia in HD patients [24] and another has
revealed normocytic normochromic anaemia in 81% of HD
patients [25]. The pathogenesis of uremic bleeding is not fully
understood. No major alterations of the plasma coagulation
factors have been reported, and the fibrinolytic system does
not appear to be impaired. The common haematological
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manifestations of uremia are ecchymosis, purpura, epistaxis,
and bleeding from venopuncture sites. Cardiac tamponade
following pericarditis and pleural effusion can also occur.
Spontaneous sub-capsular haematoma of the liver is a major
complication, as are subdural haematomas. Uremic bleeding
has also been attributed to a quantitative platelet reduction in
20% to 52% of the cases [26,27]. The exact mechanism behind
the elevated erythrocyte sedimentation rate (ESR) in ESRD is
not clear. Table 3 provides a summary of haematology in ESRD
patients.





Anaemia of Chronic Disorders
Iron Deficiency-Blood loss, e.g. venesection, defective platelet function
Folate deficiency-Chronic HD without replacement therapy
Abnormal Platelet Function
Thrombocytopenia
Immune complex-mediated, e.g. systemic lupus erythematosus (SLE)
Polyarteritis nodosa (PN)
Some cases of acute nephritis following allograft
Hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura
(TTP)
Thrombosis
Some cases of nephrotic syndrome (NS)
Polycythemia
In renal allograft recipients
Rare in renal cell carcinoma, cysts, arterial disease
Ref: Table adapted from [28]
Physical Activity in Renal Patients
One study observed 18 HD patients, 12 continuous
ambulatory peritoneal dialysis (CAPD) patients and 20 post-
transplant patients performed maximal treadmill exercise
tests. Heart rates and blood pressures were determined every
minute and maximal oxygen consumption was measured
directly [28]. Exercise capacity as measured by VO2 max is low
in HD patients and is similar to inactive untreated renal
transplant patients. Maximal heart rates were significantly
lower in haemodialysis patients than transplant recipients. The
lower exercise tolerance in end-stage renal disease (ESRD)
indicates that most patients regardless of the treatment mode
could benefit from attempts through exercise training to
increase physical working capacity [29].
Another investigation explored the effects in uremic
patients of handgrip exercise on plasma catecholamine levels,
neuropeptide-Y (NPY), and leu-enkephalin before and after HD
[30]. In this study dopamine levels were higher in the uremic
group before than after HD treatment both during rest (0.38
pmol/ml ± 0.39 pmol/ml and handgrip exercise 1.13 pmol/ml ±
1.00 pmol/ml compared to controls 0.17 pmol/ml ± 0.19
pmol/ml, and 0.66 pmol/ml ± 0.83 pmol/ml). HD treatment led
to further increase in dopamine 0.49 pmol/ml ± 0.35 pmol/ml
at rest. Noradrenaline levels were almost the same in uremic
patients before 0.43 pmol/ml ± 0.51 pmol/ml and after dialysis
0.46 pmol/ml ± 0.60 pmol/ml as in control subjects 0.41
pmol/ml ± 0.37 pmol/ml during rest. The level measured after
the handgrip was the highest in the uremic group after dialysis
2.10 pmol/ml ± 2.00 pmol/ml, significantly lower before
dialysis 1.26 pmol/ml ± 0.85 pmol/ml, and the lowest in
control group 0.78 pmol/ml ± 0.43 pmol/ml [30].
Noradrenaline levels were very similar in the uremic group
before dialysis (1.54 pmol/ml ± 1.05 pmol/ml, after dialysis
1.79 pmol/ml ± 1.29 pmol/ml and in the control group 1.46
pmol/ml ± 1.06 pmol/ml) at rest. During the handgrip test its
level was higher in uremic group after HD than before it
(adequate values 8.78 pmol/ml ± 4.61 pmol/ml and 6.70
pmol/ml ± 4.74 pmol/ml). The difference between uremia
group before dialysis and control group did not reach
significance. The level of NPY has the tendency to increase in
uremic patients. HD leads to following increase of its level, but
the changes did not reach the significance both in rest and
handgrip. Leu-enkephalin level was higher in uremic group
(9.21 ± 7.62 pmol/ml) compared to control group (5.22 ± 1.53
pmol/ml). The team identified that there was a non-significant
fall of this parameter post HD (6.79 ± 4.76 pmol/ml). This team
established that uremia leads to increase the level of
dopamine and Leu-enkephalin during rest and handgrip, but
the level of epinephrine only during the handgrip. HD
treatment led to further increase of dopamine during rest, but
epinephrine, norepinephrine and Leu-enkephalin only during
handgrip exercise [30].
Physical Activity in CAPD Patients
In a study on exercise tolerance, blood biochemistry, blood
pressure (BP) control, cardiac function, and quality of life
(QOL) over a 12-week exercise program [31], scores were
calculated from 13 patients undergoing continuous
ambulatory peritoneal dialysis (CAPD; six men and seven
women of mean age, 46.5 ± 12.8 years, and with a mean
duration of dialysis of 4.8 ± 3.8 years). The patients underwent
exercise training using treadmill running or cycling with arm
ergometers three times a week. Seven CAPD patients who
were matched for age, sex, and duration on dialysis served as
controls.
The mean peak aerobic capacity (VO2 peak) of the patients
increased by 16.2% after training (pre- and post-exercise, 17.2
± 5.2 mL/kg/min v 20.0 ± 6.4 mL/kg/min; P=0.004) [31].
Although there were no significant changes in serum urea,
creatinine, albumin, hematocrit levels, left ventricular
diastolic/systolic diameter ratio and ejection fraction, an
increasing trend in plasma high-density lipoproteins (HDLs)
was observed (baseline vs. post exercise, 33 ± 11 mg/dL v 40 ±
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14 mg/dL; P=0.06). Twenty four hour ambulatory BP
monitoring indicated a significant increase in daytime systolic
BP (pre- and post-exercise, 142 ± 26 mmHg v 157+/-22 mmHg;
P=0.003), but no significant changes could be found in the
ambulatory daytime diastolic BP, nocturnal BP, and resting
clinic BP. The patients' QOL improved after training, with
better scores in two of the kidney disease quality of life scales
(KDQOL): burden of kidney disease and physical functioning.
Two mild and uncomplicated hypotensive episodes were
reported in two patients immediately after training. No
changes occurred in exercise capacity, blood biochemistry, BP
profile, and QOL scores in the controls. The team concludes
that structured aerobic exercise is safe and can improve the
exercise tolerance and QOL outcomes in CAPD patients [31].
Another study investigated factors that influence peak VO2 in
patients receiving CAPD [32]. The study included 22 ESRD
patients (12 men, 10 women; ages 29.64 ± 8.29 years; CAPD
duration, 37.35 months ± 7.15 months). The results suggested
that low physical activity might be related to serum
phosphorus levels, and that optimal control of serum
phosphorus therapy would increase exercise capacity,
duration, and oxygen consumption; resulting in a decrease of
post-operative mortality in renal transplant candidates [32].
Physical Activity in HD Patients
In further work to determine the effects of physical activity
on left ventricular function at rest and during sub maximal
effort, thirty-eight ESRD patients maintained on HD were
recruited and randomized into three groups [31]. Sixteen
patients (Group A - mean age 46.4 ± 13.9 years, without
clinical features of heart failure) participated in a 6 month
renal rehabilitation program with supervised exercise
consisting of three weekly sessions of aerobic training. A
further ten patients (Group B - mean age 51.4 ± 12.5 years)
followed a moderate exercise program at home. A final group
of twelve (Group C - mean age 50.2 ± 7.9 years) were not
trained and remained as controls. The level of anaemia and
the HD prescription remained constant in all groups during the
study [33]. A healthy control group comprised fifteen sex- and
age-matched inactive individuals (Group D - mean age 46.9 ±
6.4 years were the healthy controls. All patients at the start
and end of the program underwent physical examination,
laboratory tests, treadmill exercise testing, M-mode and 2-D
echocardiograms performed at rest and at peak of supine
bicycle exercise. Left ventricular volumes (EDV, ESV) and mass
(LVM) were measured and ejection fraction (EF), stroke volume
index (SVI) and cardiac output index (COI) were calculated
using the standard formulae. The maximal oxygen
consumption increased by 43% (P=0.001) and the exercise
time by 33% (P=0.001) after training in group A, by 17%
(P=0.001) and 14% (P=0.01), respectively, in B, and both
remained unchanged in Group C. Training in Group A was also
associated with an increase in LVIDd (from 52.1 ± 6.4 mm to
54.0 ± 6.1 mm, P=0.001) and LVM (226 ± 67 g to 240 ± 84 g,
P=0.05) at rest with no change noted in Groups B and C.
Following a 6 month exercise training in Group A, an increase
was also found in the resting EF by 5%=0.01) and SVI by 14%
(P=0.001). There were no changes in these parameters in
Groups B and C [33]. Supine bicycle exercise after training in
Group A was associated with an improvement in EF by 14%
compared to the pre-training change (P=0.001), SVI increased
by 14% (P=0.001) and COI by 73% (P=0.001). There were
similar but less pronounced changes from rest to sub maximal
exercise in Group B following training at home. The untrained
patients showed no changes in LV systolic function over the 6
month period. The study demonstrated that intense exercise
training improves LV systolic function at rest in HD patients;
both intense and moderate physical activity led to enhanced
cardiac performance during supine sub maximal exercise [33].
Another study investigated when physical activity can
reduce urea, creatinine, and potassium during HD [34]. Eleven
patients (aged 32-78 years) on HD (4-58 months duration)
were studied on paired HD sessions; one with exercise and the
other as a control. Patients cycled for 5-20 min at sub maximal
workload, and the exercise was followed by 10 min rest to
achieve a total 60 min exercise period. Plasma concentrations
of urea, creatinine and potassium were measured pre-, post-
and 30-min post HD. The post-dialysis rebound (% rebound)
and reduction ratios (RR) of the solutes and equilibrated (two-
pool) urea and Kt/V were calculated for comparison [34].
Results demonstrate rebounds of all three solutes were
reduced following exercise. The rebound of urea decreased
from 12.4% to 10.9% (median, P=0.01; Wilcoxon signed rank
test), creatinine from 21.2% to 17.2% (P=0.001) and potassium
from 62% to 44% (P=0.05). Kt/V and RR increased significantly
as a result: Kt/V urea from 1.00 to 1.15 (P=0.001), RR urea
from 0.63 to 0.68 (P=0.001); Kt/V creatinine from 0.71 to 0.84
(P=0.01); and RR creatinine from 0.51 to 0.57 (P=0.05). From
the results it was concluded that exercise increased the
efficiency of HD by reducing the rebound of solutes due to
increased perfusion of the skeletal muscle [34].
Physical Activity and HD Adequacy
A further study investigated the effect of exercise on HD
adequacy [35]. Twenty (20) studies were performed in 20
maintenance HD patients. An adapted exercise cycle was
attached to the dialysis bed. The patients in exercise group
pedaled throughout dialysis, and had a 5-10 minutes rest if
they needed, while the patients of a control group had no
exercise. Blood, urea and nitrogen (BUN), serum creatinine
(SCr) and urea were measured just before and after HD
immediately, and 60 minutes post HD. In the exercise group,
after HD, both BUN and SCr rates were shown to be
significantly higher, whilst the rebound of BUN, SCr and Urea
were significantly lower than those in the control group
(P<0.05, approximately 0.01). Kt/V was also higher in the
exercise group (P<0.05, approximately 0.01). The results
showed that exercise during HD is a practical new way to
improve the dialysis adequacy [35].
Physical training is being recommended as a complementary
therapeutic approach [34]. This is supported by a study in
which three methods of exercise training were evaluated in
patients with ESRD: These were (1) a supervised outpatient
programme that is held in a rehabilitation center; (2) a home
exercise rehabilitation programme; and (3) an exercise
Annals of Clinical and Laboratory Research
ISSN 2386-5180 Vol.4 No.3:109
2016
© Copyright iMedPub 5
rehabilitation programme undertaken during the first few
hours of the HD treatment in a renal unit. Training data show
that the application of an exercise training programme in
patients with ESRD enhances their physical fitness. This
improvement is due to central and mainly peripheral
adaptations [36]. Physical activity training in HD patients
increases aerobic capacity, causes favorable left ventricular
functional adaptations, reduces blood pressure in patients
with hypertension, modifies other coronary risk factors,
increases the cardiac vagal activity and suppresses the
incidence of cardiac arrhythmias. Moreover, physical training
has beneficial effects on muscle structural and functional
abnormalities [36]. The study established that central and
peripheral adaptations to training cause an increase in their
functional capacity and offer them a better chance of coping.
Moreover, physical activity improves exercise tolerance of
renal post-transplant patients [36].
Physical Activity and Health
Perception
A further study investigated the effects of 2 methods of
long-term physical training on physical fitness, perception of
health and overall life situation in HD patients [37]. Forty eight
HD patients who were free of any other systemic disease, and
who each used two methods of exercise training for duration
off our years, were studied. Half of the patients (Group A)
were randomly assigned to a supervised outpatient exercise
training program (three times weekly) on the non-HD days,
whilst the other half (Group B) followed a training program
with stationary bicycles during their HD sessions (3/weekly).
The physical fitness and well-being parameters which were
measured every year were: 1) aerobic capacity, as estimated
from a modified treadmill exercise test and spiroergometric
study, 2) the patients' perception of their health, 3) the overall
life situation and 4) employment status [37]. During the study,
there were 8 drop-outs in Group A and 5 in B. No adverse
effects of the exercise programs were reported. The one year
of exercise training resulted in 38% in group A (16 patients)
and 31% in group B (18 patients) improving their exercise time,
a 47% increase in Group A of peak oxygen consumption
(VO2peak) and a 36% in group B by comparison to the baseline
value [37]. After three additional years of training, significant
improvements were also noted in exercise time (by 53% in
Group A and by 43% in B) and VO2peak (by 70% in Group A
and by 50% in Group B), as well as in other gas exchange
variables in comparison to baseline values. However, the
improvements in Group A were more pronounced than in B.
Interestingly, the gains in exercise capacity were more
enhanced in the first year of training in both groups. After four
years of training, significantly more patients in both groups
perceived their health and overall life situation as being
improved compared to baseline. In addition, perception of
improved health was higher in Group A. In conclusion, the
study established that HD patients can adhere to long-term
physical activity programmes on non-HD days, as well as
during HD with considerable improvements in physical fitness
and health [37].
Diet and Nutrition
HD patients have many concerns when it comes to eating
the ‘right food'. The diet of a HD patient is somewhat different
to that of a patient post-transplant. Because the majority of
HD recipients do not have adequate renal function, this will
cause some parameters to be unstable, particularly creatinine
(relatively high), urea (high), phosphate (high, controlled with
phosphate binders and potentially parathyroidectomy), and
calcium (unstable, but controlled with calcium supplement/s).
Potassium is also important to keep in control because at
abnormal levels will cause hyperkalemia, causing arrhythmia.
Potassium is reduced within the first hour of HD and this
combined with muscle contraction will mildly effect calcium
stores. As for urea and creatinine, these will not increase in
patients who partake in exhaustive exercise because–physical
activity should decrease these parameters [18].
Post exercise, it's sensible to take in carbohydrates, so the
body is able to maintain energy; it is important that protein is
part of a HD patient's normal diet because this allows strength
building (muscle mass) [18]. Protein is an element in specific
food (all types of fish, meat, and chicken).
Muscle mass tends to be reduced in the elder HD recipient,
because the diet of an older patient will differ from younger
patients. Exercise should decrease urea, decrease sodium,
decrease potassium, increase appetite and potentially red
cell/HB turnover with the aid of erythropoietin (EPO)
prescription.
Discussion
The RRT patient will undergo various procedures and
protocols; some being more traumatic than others. However,
patients should challenge negative implications by being
involved physical activity. Patients will not know how long they
will be on either treatment forms and for this reason they
should be encouraged (or prescribed) to get involved in fitness
programmes, which has obvious benefits. The majority of
literature in this article favors exercise for the dialysis patient
because ultimately it can improve outlook. Exhaustive exercise
does improve HD efficacy and ultimately it can aid in the run
up and preparation for a renal transplant, but not all patients
will be able to tolerate such advanced activity owing to longer-
term effects of HD [38]. It seems obvious there are various
ways that HD efficacy can be enhanced through physical
activity [39,40]. Research has shown that physical activity
increases the efficiency of HD by reducing tissue solute
composition due to increased perfusion of the skeletal muscles
[32]. Research has also identified that exercise during HD is a
practicable new way to improve HD efficiency [33]. Though
debatable, perhaps the counter argument to this is that
patients should not exercise during HD because they may
experience reduced oxygen as red cells are continuously being
turned over and patients may become prone to cramping as a
complication, which then leads to hypotensive episodes.
Perhaps one of the main recommendations is thus to see that
patients partake in physical activity before/in between their
HD sessions or at least 2-4 hours before. In turn, patients will
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find that they feel better and ultimately find this improves
treatment efficacy and urea clearance. Patients would also feel
more energized if exercise is routine.
Conclusion
Physical activity as part of routine RRT has various benefits
and it is evident that more research contributing to physical
activity/exercise in renal patients is needed [41]. More
research and studies are prompting discussion [42,43].
However, when exploring the larger role of physical activity in
this patient population, it is important to inter-relate
biochemical and haematological parameters, thus allowing a
better picture of how blood and chemistry can improve in
patients undergoing a HD regimen. There are limited studies
exploring haematology parameters in HD patients who partake
in physical activity and this may be due to general
understanding that most HD patients have low hemoglobin
levels. The immune system also plays a role. With most
patients having co-morbidities, it would otherwise be good to
see more research that associates physical activity with
endocrinology in patients with ESRD, (i.e. to understand how
HD patients' and their parameters are affected with
psychological stress and β-endorphins). Certainly more
longitudinal and cross-sectional studies are required to inform
future care and practices.
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